| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |